1 Viral Infection & Disease
2 Bacterial Infection & Disease
3 Bacterial Susceptibility & Resistance
4 Diagnostic Bacteriology & General Microbiology
5 New Antibacterial Agents, PK/PD & Stewardship
6 Fungal Infection & Disease
7 Parasitic Diseases & International Health
8 Healthcare-associated & Nosocomial Infections, Infection Control
9 Experimental Microbiology, Microbial Pathogenesis & Biofilm
10 Immunology & Vaccinology
11 Other

1 Viral Infection & Disease

a. HIV/AIDS (incl anti-retroviral drugs, treatment & susceptibility/resistance, diagnostics & epidemiology)

b. Viral hepatitis (incl antiviral drugs, treatment & susceptibility/resistance, diagnostics & epidemiology)

c. Influenza and respiratory viruses

d. Emerging/re-emerging and zoonotic viral diseases

e. Antiviral drugs, treatment, susceptibility/resistance (other than hepatitis & HIV)

f. Viral molecular epidemiology (other than hepatitis & HIV)

g. Diagnostic virology (other than hepatitis & HIV)

h. Other

2 Bacterial Infection & Disease

a. Tuberculosis and other mycobacterial infections

b. Severe sepsis, bacteraemia & endocarditis

c. Community-acquired respiratory infections

d. Abdominal/gastrointestinal, urinary tract & genital infections

e. Skin, soft tissue, bone & joint & central nervous system infections

f. Zoonotic bacterial diseases

g. Other

3 Bacterial Susceptibility & Resistance

a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives

b. Resistance surveillance & epidemiology: Gram-negatives

c. Susceptibility testing methods

d. Resistance mechanisms

e. Other

4 Diagnostic Bacteriology & General Microbiology

a. Diagnostic bacteriology – culture based

b. Diagnostic bacteriology – non-culture based, including molecular and MALDI-TOF

c. Molecular bacterial typing methods

d. Laboratory automation

e. General microbiology

f. Other

5 New Antibacterial Agents, PK/PD & Stewardship

a. Mechanisms of action, preclinical data & pharmacology of antibacterial agents

b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring

c. New antibacterial agents: clinical trials

d. Pharmacoepidemiology, improved prescribing and antibiotic stewardship

e. Other

6 Fungal Infection & Disease

a. Fungal disease epidemiology & clinical trials

b. Diagnostic mycology (incl molecular)

c. Antifungal drugs & treatment

d. Antifungal resistance & susceptibility testing

e. Other

7 Parasitic Diseases & International Health

a. Diagnostic parasitology

b. Antiparasitic susceptibility & resistance

c. Antiparasitic drugs & treatment

d. Parasitic disease epidemiology

e. Travel medicine & migrant health

f. International & public health

g. Other

8 Healthcare-associated & Nosocomial Infections, Infection Control

a. Intravascular catheter-related infections

b. Other foreign-body and implant infections

c. Surgical site infections

d. Nosocomial infection surveillance & epidemiology

e. Infection control interventional trials

f. Disinfection & biocides

g. Other

9 Experimental Microbiology, Microbial Pathogenesis & Biofilm

a. Microbial pathogenesis & virulence

b. Host-pathogen interaction

c. Preclinical biofilm studies

d. Experimental and cellular microbiology

e. Other

10 Immunology & Vaccinology

a. Host genetics: infection susceptibility & immunodeficiency

b. Clinical epidemiology of infections in immunocompromised hosts

c. General vaccinology

d. Antiviral vaccines

e. Antibacterial vaccines

f. Other

11 Other